MSOS ETF

AdvisorShares Pure US Cannabis ETF has plummeted 65% since last year, with recent declines driven by Florida's failed legalization vote and MJUS liquidation news. MSOS remains poorly diversified, with top holdings Green Thumb Industries, Trulieve, and Curaleaf now representing 70% of the fund, raising concerns about its weighting. Potential redemptions could further pressure MSOS, but eliminating 280E taxation might improve financials and sentiment, offering a possible bounce.

AI stocks have been phenomenal investments in recent years, but investors are paying a high price for them today. Growth investors can generate better returns by targeting undervalued stocks that may have more upside.

Cannabis demand is high, but investing challenges hinder industry growth due to lack of federal framework. AdvisorShares Pure US Cannabis ETF focuses on US-based cannabis companies, excluding Canadian exposures. MSOS is a basket of top-tier US cannabis companies using swap agreements due to lack of federal legalization, with high concentration and potential volatility.

Traditionally, ETF investors expect to face expense ratios to compensate fund providers and managers for their investments. However, that is not always the case.

This week on ETF Prime, host Nate Geraci is joined by VettaFi's Head of Research Todd Rosenbluth to talk about hedge funds adopting ETFs, the emergence of spot ether ETFs, and a potential lack of ETF tickers. Later on, Bancreek's CEO and CIO Andrew Skatoff discusses his investment strategy with Geraci.

Investors looking for momentum may be considering the AdvisorShares Pure US Cannabis ETF (MSOS), as the fund recently reached a 52-week high and has increased by 137.66% from its low of $4.78/share.

Shares associated with marijuana experienced a sharp increase on a day when the overall market was down.

Hopes for a long-awaited measure that would allow legal cannabis companies to access the federal banking system have been crushed this week, according to an executive at a major dispensary-payments company speaking to MarketWatch.

Virginia Republican Gov. Glenn Youngkin vetoed a measure that would have established a legal recreational-cannabis market because, as he said, ”Cannabis is bad” for the state.